Background: Premenstrual mood symptoms are considered common in women, but such prevailing attitudes are shaped by social expectations about gender, emotionality and hormonal influences. There are few prospective, community studies of women reporting mood data from all phases of the menstrual cycle (MC). We aimed (i) to analyze daily mood data over 6 months for MC phase cyclicity and (ii) to compare MC phase influences on a woman’s daily mood with that attributable to key alternate explanatory variables (physical health, perceived stress and social support). Method: A random sample of Canadian women aged 18–40 years collected mood and health data daily over 6 months, using telemetry, producing 395 complete MCs for analysis. Results: Only half the individual mood items showed any MC phase association; these links were either with the menses phase alone or the menses plus the premenstrual phase. With one exception, the association was not solely premenstrual. The menses-follicular-luteal MC division gave similar results. Less than 0.5% of the women’s individual periodogram records for each mood item showed MC entrainment. Physical health, perceived stress and social support were much stronger predictors of mood (p < 0.0001 in each case) than MC phase. Conclusions: The results of this study do not support the widespread idea of specific premenstrual dysphoria in women. Daily physical health status, perceived stress and social support explain daily mood better than MC phase.

1.
Yonkers KA, O’Brien PM, Eriksson E: Premenstrual syndrome. Lancet 2008;371:1200–1210.
2.
Gonda X, Telek T, Juhasz G, Lazary J, Vargha A, Bagdy G: Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1782–1788.
3.
American Psychiatric Association: Diagnostic and statistical manual – text revision (DSM-IV-TR), ed 4. Washington, American Psychiatric Association, 2000.
4.
Dalton K: The influence of menstruation on health and disease. Proc R Soc Med 1964;57:262–264.
5.
Johnson TM: Premenstrual syndrome as a western culture-specific disorder. Cult Med Psychiatry 1987;11:337–356.
6.
Rodin M: The social construction of premenstrual syndrome. Soc Sci Med 1992;35:49–56.
7.
Ussher JM: Research and theory related to female reproduction: implications for clinical psychology. Br J Clin Psychol 1992;31:129–151.
8.
Walker A: Theory and methodology in premenstrual syndrome research. Soc Sci Med 1995;41:793–800.
9.
Stolberg M: The monthly malady: a history of premenstrual suffering. Med Hist 2000;44:301–322.
10.
Bancroft J: The menstrual cycle and the well-being of women. Soc Sci Med 1995;41:785–791.
11.
McFarlane JM, Williams TM: Placing premenstrual syndrome in perspective. Psychol Women Q 1994;18:339–373.
12.
Marvan ML, Escobedo C: Premenstrual symptomatology: role of prior knowledge about premenstrual syndrome. Psychosom Med 1999;61:163–167.
13.
Singer JD, Willett JB: Applied Longitudinal Analysis: Modeling Change and Event Occurrence. Oxford, Oxford University Press, 2003.
14.
McEwen BS: From molecules to mind. Stress, individual differences, and the social environment. Ann NY Acad Sci 2001;935:42–49.
15.
Kawachi I, Berkman LF: Social ties and mental health. J Urban Health 2001;78:458–467.
16.
House JS: Understanding social factors and inequalities in health: 20th century progress and 21st century prospects. J Health Soc Behav 2002;43:125–142.
17.
Kendler KS, Gardner CO, Prescott CA: Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 2002;159:1133–1145.
18.
McEwen BS: Mood disorders and allostatic load. Biol Psychiatry 2003;54:200–207.
19.
Kopp MS, Stauder A, Purebl G, Janszky I, Skrabski A: Work stress and mental health in a changing society. Eur J Public Health 2008;18:238–244.
20.
Pressman SD, Cohen S: Does positive affect influence health? Psychol Bull 2005;131:925–971.
21.
Anson O: Exploring the bio-psycho-social approach to premenstrual experiences. Soc Sci Med 1999;49:67–80.
22.
Sigmon ST, Dorhofer DM, Rohan KJ, Boulard NE: The impact of anxiety sensitivity, bodily expectations, and cultural beliefs on menstrual symptom reporting: a test of the menstrual reactivity hypothesis. J Anxiety Disord 2000;14:615–633.
23.
Koff E, Rierdan J: Premenarcheal expectations and postmenarcheal experiences of positive and negative menstrual-related changes. J Adolesc Health 1996;18:286–291.
24.
Woods NF, Mitchell ES, Lentz MJ: Social pathways to premenstrual symptoms. Res Nurs Health 1995;18:225–237.
25.
Kreindler D, Levitt A, Woolridge N, Lumsden CJ: Portable mood mapping: the validity and reliability of analog scale displays for mood assessment via hand-held computer. Psychiatry Res 2003;120:165–177.
26.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22–33, quiz 34–57.
27.
Parkinson B, Briner RB, Reynolds S, Totterdell P: Time frames for mood: relations between momentary and generalized ratings of affect. Pers Soc Psychol Rev 1995;21:331–339.
28.
Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR: Patient compliance with paper and electronic diaries. Control Clin Trials 2003;24:182–199.
29.
Piasecki TM, Hufford MR, Solhan M, Trull TJ: Assessing clients in their natural environments with electronic diaries: rationale, benefits, limitations, and barriers. Psychol Assess 2007;19:25–43.
30.
Woods NF: Premenstrual symptoms: another look. Public Health Rep 1987;102(suppl 4):106–112.
31.
Metcalf MG, Livesey JH: Distribution of positive moods in women with the premenstrual syndrome and in normal women. J Psychosom Res 1995;39:609–618.
32.
Allen SS, McBride CM, Pirie PL: The shortened premenstrual assessment form. J Reprod Med 1991;36:769–772.
33.
Society for Menstrual Cycle Research: Task force report on guidelines for menstrual cycle research. Newsletter Soc Menstrual Cycle Res 1986;2:1–2.
34.
Waller K, Swan SH, Windham GC, Fenster L, Elkin EP, Lasley BL: Use of urine biomarkers to evaluate menstrual function in healthy premenopausal women. Am J Epidemiol 1998;147:1071–1080.
35.
Kreindler D, Lumsden C: The effects of irregular sampling and missing data in time series analysis. Nonlinear Dynamics Psychol Life Sci 2006;10:187–214.
36.
Lomb N: Least-squares analysis of unequally spaced data. Astrophys Space Sci 1976;39:4474–4462.
37.
Press WH, Teukolsky SA, Vetterling WT, Flannery BP: Numerical Recipes in C: The Art of Scientific Computing, ed 2. New York, Cambridge University Press, 1993.
38.
Van Dongen H, Olofsen E, Van Hartevelt J, Kruy E (eds): Periodogram Analysis of Unequally Spaced Data: The Lomb Method. Leiden, Leiden University, 1997.
39.
Woods NF, Most A, Dery GK: Prevalence of perimenstrual symptoms. Am J Public Health 1982;72:1257–1264.
40.
Angst J, Sellaro R, Merikangas KR, Endicott J: The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 2001;104:110–116.
41.
Fava GA, Ruini C, Tomba E, Wise TN: The biopsychosocial factor. Psychother Psychosom 2012;81:1–4.
42.
Bolger N, Davis A, Rafaeli E: Diary methods: capturing life as it is lived. Annu Rev Psychol 2003;54:579–616.
43.
Burton C, Weller D, Sharpe M: Are electronic diaries useful for symptoms research? A systematic review. J Psychosom Res 2007;62:553–561.
44.
Woods NF, Most A, Dery GK: Toward a construct of perimenstrual distress. Res Nurs Health 1982;5:123–136.
45.
Sveinsdottir H: Prospective assessment of menstrual and premenstrual experiences of Icelandic women. Health Care Women Int 1998;19:71–82.
46.
Meaden PM, Hartlage SA, Cook-Karr J: Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States. Psychiatry Res 2005;134:27–36.
47.
Bakhtin M: Rabelais and his world. Bloomington, Indiana University Press, 1941.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.